Replies to post #129504 on Biotech Values

[DewDiligence]

On the Biogen call there was a question about combining [BG-12] with other agents and they remarked something to the effect of with the efficacy they saw they don't see a need to.

If BIIB doesn’t test such combination regimens, others will.